AIM-IBD: A Phase 2b Trial of a Microbiome-Targeted Investigational Product in Ulcerative Colitis

Conditions: Ulcerative Colitis (UC); Inflammatory Bowel Disease (IBD); Colitis

Interventions: Dietary Supplement: Microbiome-Targeting Nutraceutical; Dietary Supplement: Placebo

Sponsors: ENBIOSIS BIOTECHNOLOGIES; Aydin Adnan Menderes University; Ege University Medical School; Dokuz Eylul University; Tepecik Training and Research Hospital

Not yet recruiting